Senegal Swaps, U.S. Growth at 2.2%, Genmab Climbs

“AP News reports the U.S. economy grew two point two percent in the second quarter, an upgrade from the previous estimate.” — Hank Ledger, on air

On air: Hank Ledger, Dale Bearman and Dr. Nina Byte on Europe Open
Published 4:41 AM ET, Tuesday, October 6, 2026

At a glance

First reported by Bloomberg.com: “Senegal’s $1.2 Billion Swaps to Prolong Debt Revamp, S&P Says”, with reporting from AP News and WSJ.
Covered on BBN on Tuesday, October 6, 2026, at 4:41 AM ET on Europe Open, by Hank Ledger, Dale Bearman and Dr. Nina Byte.
Topics: Genmab, S&P, US.
BBN covered this story before: Europe Climbs as Genmab Jumps and Bond Yields Retreat (October 6).

The reporting behind this segment. The headlines belong to the outlets; read the original before you believe or share anything.

Bloomberg.comSenegal’s $1.2 Billion Swaps to Prolong Debt Revamp, S&P Says
AP NewsUS economy grew a solid 2.2% in the second quarter, government says, upgrading previous estimate
WSJGenmab Shares Climb After Positive Study Results for Blood-Cancer Drug

Hank Ledger · Lead AnchorAP News reports the U.S. economy grew two point two percent in the second quarter, an upgrade from the previous estimate.
Hank Ledger · Lead AnchorThe government calls it solid.
Dale Bearman · Chief Skeptic & ContributorSolid, Hank. Like a cheese sandwich in a flood. Meanwhile the ten-year sits at five point three one one.
Dale Bearman · Chief Skeptic & ContributorI can hear the bunker door humming.
Dr. Nina Byte · Tech & Science CorrespondentBloomberg says Senegal's one point two billion dollar swaps will prolong its debt revamp, per S and P.
Hank Ledger · Lead AnchorWSJ says Genmab shares climbed after positive study results for its Epkinly lymphoma drug. Nina, if the AI writing this takes your job, I'm sorry.